D. Ahnen

D. Ahnen, M. Wargovich, R. Guerciolini, 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Protooncogene abnormalities in colon cancers and adenomatous polyps.

J. Yokota, D. Ahnen, S. Meltzer, 1987, Gastroenterology.

NCCN Guidelines(r) insights colorectal cancer screening, version 1.2018 featured updates to the NCCN guidelines

M. Dwyer, J. Ford, G. Cooper, 2018 .

Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on Outcome.

R. Bostick, J. Baron, T. Church, 2017, Gastroenterology.

Intestinal surface aminooligopeptidase. Distinct molecular forms during assembly on intracellular membranes in vivo.

D. Ahnen, G. M. Gray, A. Mircheff, 1983, The Journal of biological chemistry.

A proposed staging system and stage-specific interventions for familial adenomatous polyposis.

Jeffrey S. Morris, N. Matsubara, L. Ricciardiello, 2016, Gastrointestinal endoscopy.

Familial Colon Cancer Syndromes: an Update of a Rapidly Evolving Field

Swati G. Patel, D. Ahnen, 2012, Current Gastroenterology Reports.

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017.

M. Dwyer, G. Cooper, S. Regenbogen, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

A summary of the Fight Colorectal Cancer working meeting: exploring risk factors and etiology of sporadic early-age onset colorectal cancer.

Swati G. Patel, C. Boland, A. Zauber, 2019, Gastroenterology.

Barriers to Lynch Syndrome Testing and Preoperative Result Availability in Early-onset Colorectal Cancer: A National Physician Survey Study

D. Ahnen, T. Weber, J. Karlitz, 2018, Clinical and Translational Gastroenterology.

Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors

P. Laird, D. Weisenberger, J. Baron, 2015, Cancer Epidemiology, Biomarkers & Prevention.

Family History of Colorectal Cancer Is Not Associated with Colorectal Cancer Survival Regardless of Microsatellite Instability Status

Aung Ko Win, J. Potter, P. Newcomb, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Risk factors for metachronous colorectal cancer or polyp: A systematic review and meta‐analysis

Aung Ko Win, M. Jenkins, J. Reece, 2017, Journal of gastroenterology and hepatology.

Shifts in the Fecal Microbiota Associated with Adenomatous Polyps

P. Lance, D. Ahlquist, D. Ahnen, 2016, Cancer Epidemiology, Biomarkers & Prevention.

Colorectal Cancer: Myths, Facts, and Possibilities

T. Byers, D. Ahnen, S. Prindiville, 1997 .

Flow cytometric analysis of deoxyribonucleic acid content in the gastrointestinal tract. Is aneuploidy more than a new ploy?

D. Ahnen, 1987, Gastroenterology.

Five-year colon surveillance after screening colonoscopy.

Dawn Provenzale, Douglas Robertson, R. Sampliner, 2007, Gastroenterology.

Immunohistochemical testing of conventional adenomas for loss of expression of mismatch repair proteins in Lynch syndrome mutation carriers: a case series from the Australasian site of the colon cancer family registry

Aung Ko Win, J. Hopper, S. Thibodeau, 2012, Modern Pathology.

What do cancer survivors believe causes cancer? (United States)

T. Byers, D. Ahnen, L. Crane, 2005, Cancer Causes & Control.

How do researchers manage genetic results in practice? The experience of the multinational Colon Cancer Family Registry

Pamela S. Sinicrope, S. Schully, J. Hopper, 2014, Journal of Community Genetics.

Quantifying the impact of adherence to screening strategies on colorectal cancer incidence and mortality

D. Ahnen, M. Najafzadeh, D. Sussman, 2019, Cancer medicine.

Risk of Metachronous Colon Cancer Following Surgery for Rectal Cancer in Mismatch Repair Gene Mutation Carriers

Aung Ko Win, L. Lipton, J. Hopper, 2013, Annals of Surgical Oncology.

Ability of known susceptibility SNPs to predict colorectal cancer risk for persons with and without a family history

Aung Ko Win, J. Emery, J. Potter, 2018, bioRxiv.

Variable phenotype of familial adenomatous polyposis in pedigrees with 3′ mutation in the APC gene

S. Powell, D. Ahnen, G. Petersen, 1998, Gut.

Process of care and outcomes for elderly patients hospitalized with peptic ulcer disease: results from a quality improvement project.

A. Sauaia, D. Ahnen, D. Bratzler, 2001, JAMA.

Colorectal Adenomas in a Randomized Folate Trial: The Role of Baseline Dietary and Circulating Folate Levels

T. Byers, J. Baron, R. Sandler, 2008, Cancer Epidemiology Biomarkers & Prevention.

Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study.

Elizabeth L. Barry, J. Baron, R. Sandler, 2009, Journal of the National Cancer Institute.

Clinical practice. Adenomatous polyps of the colon.

D. Ahnen, J. Levine, 2006, The New England journal of medicine.

Vitamins B2, B6, and B12 and Risk of New Colorectal Adenomas in a Randomized Trial of Aspirin Use and Folic Acid Supplementation

Elizabeth L. Barry, J. Baron, R. Sandler, 2008, Cancer Epidemiology Biomarkers & Prevention.

Clinical Significance of Serrated Polyps of the Colon

D. Ahnen, Rachel Groff, 2012 .

Significance of serrated polyps of the colon

D. Ahnen, R. Nash, Rachel Groff, 2008, Current gastroenterology reports.

Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state‐of‐the‐science review

A. Zauber, W. G. Feero, M. Doerr, 2016, Cancer.

Are colorectal cancer screening recommendations for first-degree relatives of patients with adenomas too aggressive?

D. Ahnen, G. Austin, Jonathan I. Goldstein, 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Colon cancer screening for Colorado's underserved: a community clinic/academic partnership.

A. Sauaia, T. Byers, D. Ahnen, 2015, American journal of preventive medicine.

Colonoscopy training for nurse endoscopists: is it possible? Is it wise? Is it worth doing?

D. Lieberman, D. Ahnen, 2009, Gastrointestinal endoscopy.

Calcium Supplementation Increases Blood Creatinine Concentration in a Randomized Controlled Trial

Elizabeth L. Barry, R. Bostick, J. Baron, 2014, PloS one.

Validity of self-reported colorectal cancer screening behavior.

D. Ahnen, N. Calonge, Monika Baier, 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Body Composition and Aspirin Dose for Colorectal Adenoma Prevention in a Randomized Clinical Trial

J. Baron, D. Ahnen, M. N. Passarelli, 2019, Cancer Epidemiology, Biomarkers & Prevention.

A Randomized Trial of Aspirin to Prevent Colorectal Adenomas

G. Beck, T. Byers, N. Marcon, 2003 .

NCCN Genetic / Familial High-Risk Assessment : Colorectal Version 1 . 2016 Clinical Practice Guidelines in Oncology

M. Dwyer, G. Cooper, S. Regenbogen, 2016 .

Bariatric Surgery Is Associated with a Recent Temporal Increase in Colorectal Cancer Resections, Most Pronounced in Adults Below 50 Years of Age

D. Lieberman, D. Ahnen, H. Hussan, 2020, Obesity Surgery.

Genetics of colon cancer.

D. Ahnen, Dennis J. Ahnen, 1991, The Western journal of medicine.

Complex subcellular distributions of enzymatic markers in intestinal epithelial cells

D. Ahnen, G. M. Gray, A. Mircheff, 2005, The Journal of Membrane Biology.

Editorial: Serrated Polyposis: The Last (or Only the Latest?) Frontier of Familial Polyposis?

D. Ahnen, H. Lynch, S. Lanspa, 2012, The American Journal of Gastroenterology.

Gastroenterology trainees can easily learn histologic characterization of diminutive colorectal polyps with narrow band imaging.

Swati G. Patel, D. Ahnen, A. Rastogi, 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Colorectal cancer in patients under close colonoscopic surveillance.

T. Byers, J. Baron, T. Church, 2005, Gastroenterology.

Trends in Incidence of Early-Onset Colorectal Cancer in the United States Among Those Approaching Screening Age

D. Ahnen, Qingzhao Yu, J. Karlitz, 2020, JAMA network open.

Improving on‐time colorectal cancer screening through lead time messaging

D. Ahnen, P. Schroy, Whitney F Jones, 2020, Cancer.

Effect of a Mailed Brochure on Appointment-Keeping for Screening Colonoscopy

J. Steiner, T. Byers, D. Ahnen, 2006, Annals of Internal Medicine.

Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and Survival.

Jonathan M Kocarnik, J. Baron, P. Newcomb, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Antagonistic effects of aspirin and folic acid on inflammation markers and subsequent risk of recurrent colorectal adenomas.

J. Baron, R. Sandler, T. Rohan, 2009, Journal of the National Cancer Institute.

A randomized trial of aspirin to prevent colorectal adenomas.

G. Beck, T. Byers, N. Marcon, 2003, The New England journal of medicine.

Plasma lipoxin A4 and resolvin D1 are not associated with reduced adenoma risk in a randomized trial of aspirin to prevent colon adenomas

J. Baron, R. Sandler, D. Ahnen, 2017, Molecular carcinogenesis.

Smoking-associated risks of conventional adenomas and serrated polyps in the colorectum

J. Baron, J. Church, T. Church, 2014, Cancer Causes and Control.

Histamine receptor antagonists and incident colorectal adenomas

R. Sandler, D. Ahnen, R. Rothstein, 2005, Alimentary pharmacology & therapeutics.

The American College of Gastroenterology Emily Couric Lecture—The Adenoma–Carcinoma Sequence Revisited: Has the Era of Genetic Tailoring Finally Arrived?

D. Ahnen, 2011, The American Journal of Gastroenterology.

CRC Screening, Past, Present, and Future: A Tribute to Emmet Keeffe

B. Levin, D. Ahnen, R. Bresalier, 2015, Digestive Diseases and Sciences.

Survival after inflammatory bowel disease-associated colorectal cancer in the Colon Cancer Family Registry.

J. Potter, J. Baron, S. Gallinger, 2013, World journal of gastroenterology.

Knowledge and Uptake of Genetic Counseling and Colonoscopic Screening Among Individuals at Increased Risk for Lynch Syndrome and their Endoscopists from the Family Health Promotion Project

Swati G. Patel, D. Finkelstein, D. Ahnen, 2016, The American Journal of Gastroenterology.

Identification and characterization of functional risk variants for colorectal cancer mapping to chromosome 11 q 23 . 1

Elizabeth L. Barry, Simon G. Coetzee, G. Coetzee, 2014 .

Poor Knowledge of Personal and Familial Colorectal Cancer Risk and Screening Recommendations Associated with Advanced Colorectal Polyps

Swati G. Patel, D. Ahnen, A. Gumidyala, 2020, Digestive Diseases and Sciences.

Lack of Association Between Insulin Sensitivity and Colorectal Adenoma Risk

T. Byers, S. Haffner, D. Ahnen, 2010, Nutrition and cancer.

Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial.

Chiu-Hsieh Hsu, D. Alberts, A. Bhattacharyya, 2016, Journal of the National Cancer Institute.

Association between adenoma location and risk of recurrence.

J. Baron, R. Sandler, D. Ahnen, 2016, Gastrointestinal endoscopy.

Colorectal cancer survival in Europe: the Will Rogers phenomenon revisited

D. Ahnen, M. Shahrier, 2000, Gut.

Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.

Elizabeth L. Barry, C. Ulrich, G. Beck, 2007, JAMA.

Gastrin, Helicobacter pylori, and colorectal adenomas.

J. Baron, R. Sandler, D. Ahnen, 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase?

D. Alberts, D. Ahnen, R. Burt, 1995, Journal of cellular biochemistry. Supplement.

Regarding "Colorectal Cancer Screening Quality Measures: Beyond Colonoscopy".

D. Ahnen, T. Weber, P. Schroy, 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Sialosyl-Tn antigen: initial report of a new marker of malignant progression in long-standing ulcerative colitis.

D. Ahnen, A. Kornbluth, D. Sachar, 1995, Gastroenterology.

No Evidence for Posttreatment Effects of Vitamin D and Calcium Supplementation on Risk of Colorectal Adenomas in a Randomized Trial

Elizabeth L. Barry, R. Bostick, J. Baron, 2019, Cancer Prevention Research.

Calcium and vitamin D supplementation and increased risk of serrated polyps: results from a randomised clinical trial

Elizabeth L. Barry, Seth D. Crockett, J. Baron, 2018, Gut.

Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction.

G. Piazza, D. Ahnen, A. Rahm, 1997, Cancer research.

Symptomatic colonic polyps in childhood: not so benign.

A. Sauaia, D. Ahnen, E. Hoffenberg, 1999, Journal of pediatric gastroenterology and nutrition.

Genetic Variations in SMAD7 Are Associated with Colorectal Cancer Risk in the Colon Cancer Family Registry

J. Potter, J. Hopper, D. Conti, 2013, PloS one.

Secretory Component: The Receptor That Mediates External Secretion of Polymeric Immunoglobulins

D. Ahnen, W. Brown, T. M. Kloppel, 1986 .

Secretory component: The polymeric immunoglobulin receptor

D. Ahnen, W. Brown, T. M. Kloppel, 1985 .

Nuclear Accumulation of β-Catenin Occurs Commonly in the Epithelial Cells of Juvenile Polyps

K. Sugano, W. Franklin, D. Ahnen, 2005, Pediatric Research.

Role of tumor molecular and pathology features to estimate colorectal cancer risk for first-degree relatives

Aung Ko Win, J. Potter, G. Giles, 2014 .

Genetic/Familial high-risk assessment: Colorectal, version 2.2019 featured updates to the NCCN guidelines

M. Dwyer, G. Cooper, S. Regenbogen, 2019 .

Conferences and Reviews Genetics of Colon Cancer

D. Ahnen, 2022 .

Effects of milk and milk products on rectal mucosal cell proliferation in humans.

T. Tosteson, M. Karagas, D. Ahnen, 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017.

M. Dwyer, G. Cooper, S. Regenbogen, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

Sulindac sulfide inhibits epidermal growth factor-induced phosphorylation of extracellular-regulated kinase 1/2 and Bad in human colon cancer cells.

D. Ahnen, P. Rice, M. Washington, 2003, Cancer research.

Inhibition of mammary carcinogenesis in rats by sulfone metabolite of sulindac.

G. Piazza, D. Ahnen, H. Thompson, 1995, Journal of the National Cancer Institute.

Are animal models of colon cancer relevant to human disease

D. Ahnen, 1985, Digestive Diseases and Sciences.

Effects of epidermal growth factor and dimethylhydrazine on crypt size, cell proliferation, and crypt fission in the rat colon. Cell proliferation and crypt fission are controlled independently.

D. Ahnen, P. Sasieni, N. Wright, 1997, The American journal of pathology.

Proliferating cell nuclear antigen (PCNA/cyclin) immunocytochemistry as a labeling index in mouse lung tissues

A. Malkinson, D. Ahnen, L. Thaete, 1989, Cell and Tissue Research.

Serrated Lesions of the Colorectum: Review and Recommendations From an Expert Panel

Charles J. Kahi, K. Batts, J. Goldblum, 2012, The American Journal of Gastroenterology.

Ultrastructural localization of carcinoembryonic antigen in normal intestine and colon cancer. Abnormal distribution of cea on the surfaces of colon cancer cells

D. Ahnen, P. Nakane, W. Brown, 1982, Cancer.

Lessons learned from the Family Health Promotion Project

D. Ahnen, J. Lowery, 2012 .

Editorial: Colorectal Cancer and Statins: Reflections From the End of the Road

T. Byers, D. Ahnen, 2009, The American Journal of Gastroenterology.

Posttranslational processing of secretory component in the rat jejunum by a brush border metalloprotease.

D. Ahnen, T. Hoops, T. M. Kloppel, 1986, The Journal of clinical investigation.

Mo1736 Impact of Mailing Time and Season on Fecal Immunochemical Test (FIT) Positivity

P. Guarino, D. Lieberman, D. Ahnen, 2016 .

Pelvic and sacropelvic exenteration for locally advanced or recurrent anorectal cancer.

D. Ahnen, S. Sedlacek, N. Pearlman, 1987, Archives of surgery.

Are Patients With Elevated Liver Tests at Increased Risk of Drug-Induced Liver Injury?

N. Marcon, L. Ackerson, R. Sandler, 2004 .

Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumor formation by FGN-1 (sulindac sulfone).

L. Dwyer-Nield, A. Malkinson, G. Piazza, 1998, Carcinogenesis.

proposed staging system and stage-specific interventions for familial adenomatous polyposis Running Title : Polyposis staging and intervention

Jeffrey S. Morris, N. Matsubara, L. Ricciardiello, 2016 .

Search for a specific marker of mucosal dysplasia in chronic ulcerative colitis.

D. Ahnen, W. Brown, J. Singleton, 1987, Gastroenterology.

Colorectal cancer screening in average- and high-risk groups.

D. Ahnen, K. Lynch, 2001, Advances in internal medicine.

Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.

P. Bunn, D. Ahnen, C. Fenoglio-Preiser, 1998, Cancer research.

Flow cytometric analysis of deoxyribonucleic acid content in the gastrointestinal tract

D. Ahnen, 1987 .

Smoking-associated risks of conventional adenomas and serrated polyps in the colorectum

Seth D. Crockett, J. Baron, J. Church, 2014, Cancer Causes & Control.

Colon cancer prevention by NSAIDs: what is the mechanism of action?

D. Ahnen, Dennis J. Ahnen, 2003, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.

Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease.

G. Stamp, R. Poulsom, D. Ahnen, 1992, Scandinavian journal of gastroenterology. Supplement.

How do researchers manage genetic results in practice? The experience of the multinational Colon Cancer Family Registry

Pamela S. Sinicrope, S. Schully, J. Hopper, 2014, Journal of Community Genetics.

The ulceration‐associated cell lineage (UACL) reiterates the Brunner's gland differentiation programme but acquires the proliferative organization of the gastric gland

P. Chambon, G. Stamp, R. Poulsom, 1994, The Journal of pathology.

Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease.

G. Stamp, R. Poulsom, D. Ahnen, 1993, Gastroenterology.

Exisulind induction of apoptosis involves guanosine 3',5'-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated beta-catenin.

G. Piazza, D. Ahnen, B. Zhu, 2000, Cancer research.

Differential expression of carcinoembryonic antigen and secretory component during colonic epithelial cell differentiation and in colonic carcinomas

D. Ahnen, P. Nakane, W. Brown, 1987 .

Synthesis and parallel secretion of rat intestinal alkaline phosphatase and a surfactant-like particle protein.

D. Ahnen, D. Alpers, Y. Zhang, 1995, The American journal of physiology.

Characterization of ischemia-induced loss of epithelial polarity

B. Molitoris, D. Ahnen, P. Wilson, 1988, The Journal of Membrane Biology.

Intestinal aminooligopeptidase. In vivo synthesis on intracellular membranes of rat jejunum.

D. Ahnen, G. M. Gray, J. Cézard, 1982, The Journal of biological chemistry.

Predictors of nonadherence to screening colonoscopy

J. Steiner, T. Byers, D. Ahnen, 2005, Journal of General Internal Medicine.

Helicobacter pylori in peptic ulcer disease.

Fred E. Silverstein, Nicholas J. Talley, David Forman, 1994, NIH consensus statement.

Adenomatous Polyps of the Colon

D. Ahnen, J. Levine, 2006 .

Expression of cell-surface antigens on rat colonic cancer cells.

D. Ahnen, W. Brown, T. Sugiyama, 1988, Gastroenterology.

Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial

Edward S. Kim, Diane D. Liu, N. Colburn, 2008, Cancer Prevention Research.

Colorectal Cancer in the Young

Swati G. Patel, D. Ahnen, 2018, Current Gastroenterology Reports.

Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer

Aung Ko Win, J. Potter, G. Giles, 2016, Cancer Epidemiology, Biomarkers & Prevention.

Evidenced-Based Screening Strategies for a Positive Family History.

D. Ahnen, N. Samadder, J. Kolb, 2020, Gastrointestinal endoscopy clinics of North America.

Targeting EGFR in colorectal cancer.

D. Ahnen, W. Messersmith, Dennis J Ahnen, 2008, The New England journal of medicine.

Associations of Ki-ras Proto-oncogene Mutation and p53 Gene Overexpression in Sporadic Colorectal Adenomas with Demographic and Clinicopathologic Characteristics

Chiu-Hsieh Hsu, D. Alberts, E. Jacobs, 2006, Cancer Epidemiology Biomarkers & Prevention.

Ki-ras proto-oncogene mutations in sporadic colorectal adenomas: relationship to histologic and clinical characteristics.

D. Alberts, A. Bhattacharyya, T. Byers, 2001, Gastroenterology.

Expression of beta-catenin and full-length APC protein in normal and neoplastic colonic tissues.

W. Franklin, D. Ahnen, M. Iwamoto, 2000, Carcinogenesis.

Risk factors for Ki-ras protooncogene mutation in sporadic colorectal adenomas.

D. Alberts, R. Sampliner, D. Ahnen, 1999, Cancer research.

AOM-induced mouse colon tumors do not express full-length APC protein.

D. Ahnen, T. Maltzman, J. Stephens, 1997, Carcinogenesis.

Assessment of mutations in ki‐ras and p53 in colon cancers from azoxymethane‐ and dimethylhydrazine‐treated rats

D. Ahnen, E. Gerner, S. Erdman, 1997, Molecular carcinogenesis.

Increased Risk of Colorectal Cancer Tied to Advanced Colorectal Polyps: An Untapped Opportunity to Screen First-Degree Relatives and Decrease Cancer Burden.

Swati G. Patel, D. Lieberman, D. Ahnen, 2020, The American journal of gastroenterology.

The Association of Lifestyle and Dietary Factors with the Risk for Serrated Polyps of the Colorectum

J. Baron, J. Gui, D. Ahnen, 2009, Cancer Epidemiology, Biomarkers & Prevention.

Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial.

Elizabeth L. Barry, R. Bostick, C. Amos, 2014, The Journal of clinical endocrinology and metabolism.

Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study.

Aung Ko Win, G. Giles, J. Hopper, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Promoting cancer screening among the first-degree relatives of breast and colorectal cancer patients: the design of two randomized trials.

W. McCaskill-Stevens, D. Ahnen, N. Calonge, 1999, Preventive medicine.

Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels.

D. Alberts, G. Piazza, D. Ahnen, 1997, Cancer research.

Sulfone metabolite of sulindac inhibits mammary carcinogenesis.

G. Piazza, D. Ahnen, R. Mehta, 1997, Cancer research.

Association between Body Mass Index and Mortality for Colorectal Cancer Survivors: Overall and by Tumor Molecular Phenotype

Aung Ko Win, C. Ulrich, J. Potter, 2015, Cancer Epidemiology, Biomarkers & Prevention.

Association of the Colorectal CpG Island Methylator Phenotype with Molecular Features, Risk Factors, and Family History

Peter W. Laird, Kimberly D. Siegmund, Loic Le Marchand, 2015, Cancer Epidemiology, Biomarkers & Prevention.

Stool DNA and Occult Blood Testing for Screen Detection of Colorectal Neoplasia

D. Sargent, S. Hillman, D. Ahlquist, 2008, Annals of Internal Medicine.

β‐Catenin splice variants and downstream targets as markers for neoplastic progression of esophageal cancer

N. Hu, P. Taylor, S. Dawsey, 2005, Genes, chromosomes & cancer.

Randomized, placebo-controlled, esophageal squamous cell cancer chemoprevention trial of selenomethionine and celecoxib.

E. Korn, P. Taylor, S. Dawsey, 2005, Gastroenterology.

A K-ras oncogene increases resistance to sulindac-induced apoptosis in rat enterocytes.

G. Piazza, John Calvin Reed, D. Ahnen, 1997, Gastroenterology.

Controlled clinical trials: the controls are the key.

D. Ahnen, 1996, Gastroenterology.

BRAF Mutation Status and Survival after Colorectal Cancer Diagnosis According to Patient and Tumor Characteristics

John D Potter, Aung Ko Win, Michael N Passarelli, 2012, Cancer Epidemiology, Biomarkers & Prevention.

Variants Downstream of the Ornithine Decarboxylase Gene Influence Risk of Colorectal Adenoma and Aspirin Chemoprevention

Elizabeth L. Barry, J. Baron, R. Sandler, 2011, Cancer Prevention Research.

Cyclooxygenase-2 Polymorphisms, Aspirin Treatment, and Risk for Colorectal Adenoma Recurrence—Data from a Randomized Clinical Trial

J. Baron, R. Sandler, J. Gui, 2009, Cancer Epidemiology, Biomarkers & Prevention.

Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial.

R. Sampliner, D. Ahnen, R. Goyal, 2001, JAMA.

Basic concepts for genetic testing in common hereditary colorectal cancer syndromes

D. Ahnen, L. Axell, K. Markey, 2005, Current gastroenterology reports.

Basic concepts for genetic testing in common hereditary colorectal cancer syndromes

D. Ahnen, K. Markey, L. Axel, 2002 .

Association between hypermethylation of DNA repetitive elements in white blood cell DNA and early-onset colorectal cancer

Aung Ko Win, D. English, G. Giles, 2013, Epigenetics.

Benign recurrent intrahepatic cholestasis: treatment with S-adenosylmethionine.

P. C. Harper, D. Ahnen, G. Everson, 1989, Gastroenterology.

Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.

M. Dwyer, G. Cooper, S. Regenbogen, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

Substantial unexplained variation in cancer risks for MLH1 and MSH2 mutation carriers

Aung Ko Win, G. Giles, J. Hopper, 2012, Human mutation.

Association between Folate Levels and CpG Island Hypermethylation in Normal Colorectal Mucosa

Elizabeth L. Barry, J. Issa, Lanlan Shen, 2010, Cancer Prevention Research.

The increasing incidence of young-onset colorectal cancer: a call to action.

D. Ahnen, J. Axilbund, S. Wade, 2014, Mayo Clinic proceedings.

Sulindac Metabolites Induce Proteosomal and Lysosomal Degradation of the Epidermal Growth Factor Receptor

D. Ahnen, P. Rice, H. Pangburn, 2010, Cancer Prevention Research.

Sulindac metabolites inhibit epidermal growth factor receptor activation and expression

D. Ahnen, P. Rice, H. Pangburn, 2005, Journal of carcinogenesis.

Sulindac metabolites induce caspase- and proteasome-dependent degradation of beta-catenin protein in human colon cancer cells.

G. Piazza, D. Ahnen, P. Rice, 2003, Molecular cancer therapeutics.

Priorities in colorectal cancer research: recommendations from the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative Groups.

Jeffery T. Sloan, D. Sargent, N. Petrelli, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Binding of lectins to goblet cell mucin in malignant and premalignant colonic epithelium in the CF-1 mouse.

D. Ahnen, C. Boland, 1985, Gastroenterology.

Constipation and a low-fiber diet are not associated with diverticulosis.

Elizabeth L. Barry, J. Baron, R. Sandler, 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Campylobacter enteritis in immune-deficient patients.

D. Ahnen, W. Brown, 1982, Annals of internal medicine.

Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort study

Aung Ko Win, G. Giles, J. Hopper, 2016, International journal of cancer.

Female Hormonal Factors and the Risk of Endometrial Cancer in Lynch Syndrome.

Aung Ko Win, J. Potter, J. Hopper, 2015, JAMA.

The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline

A. Zauber, R. Siegel, I. Lansdorp-Vogelaar, 2018, Cancer.

Optimizing colorectal cancer screening by race and sex: Microsimulation analysis II to inform the American Cancer Society colorectal cancer screening guideline

Amy B. Knudsen, A. Zauber, R. Siegel, 2018, Cancer.

An action plan to address the rising burden of colorectal cancer in younger adults

D. Ahnen, Robert A. Smith, T. Weber, 2020 .

Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genes

Aung Ko Win, D. English, L. Lipton, 2011, British Journal of Cancer.

Proliferation, apoptosis and their regulatory protein expression in colorectal adenomas and serrated lesions

Jeffrey S. Morris, Elizabeth L. Barry, J. Baron, 2021, PloS one.

Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome.

Aung Ko Win, G. Giles, J. Hopper, 2013, Journal of the National Cancer Institute.

Folic acid supplementation and risk of colorectal neoplasia during long-term follow-up of a randomized clinical trial.

Elizabeth L. Barry, J. Baron, D. Ahnen, 2019, The American journal of clinical nutrition.

Colorectal cancer screening, version 1.2015: Featured updates to the NCCN guidelines

Shivan J. Mehta, Swati G. Patel, M. Dwyer, 2015 .

Acceleration in colorectal carcinogenesis: the hare, the tortoise or myth?

D. Ahnen, F. Macrae, 2012, Gut.

Primary prevention of colorectal cancer: diet and drugs

D. Ahnen, D. Gatof, 2003 .

Primary prevention of colorectal cancer: diet and drugs.

D. Ahnen, D. Gatof, 2002, Gastroenterology clinics of North America.

PIK3CA Somatic Mutation Status in Relation to Patient and Tumor Factors in Racial/Ethnic Minorities with Colorectal Cancer

Aung Ko Win, P. Newcomb, D. Ahnen, 2015, Cancer Epidemiology, Biomarkers & Prevention.

Lack of significant association between serum inflammatory cytokine profiles and the presence of colorectal adenoma

T. Byers, S. Haffner, D. Ahnen, 2015, BMC Cancer.

Chemoprevention of hereditary colon cancers: time for new strategies

L. Ricciardiello, D. Ahnen, P. Lynch, 2016, Nature Reviews Gastroenterology &Hepatology.

Status of Competency-Based Medical Education in Endoscopy Training: A Nationwide Survey of US ACGME-Accredited Gastroenterology Training Programs

D. Ahnen, S. Saini, P. Schoenfeld, 2015, The American Journal of Gastroenterology.

Review and analysis of the effects of olestra, a dietary fat substitute, on gastrointestinal function and symptoms.

R. Hunt, J. Freston, R. Sandler, 1997, Regulatory toxicology and pharmacology : RTP.

Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes.

Chiu-Hsieh Hsu, D. Alberts, A. Bhattacharyya, 2016, Journal of the National Cancer Institute.

Polymorphisms in Base Excision Repair Genes as Colorectal Cancer Risk Factors and Modifiers of the Effect of Diets High in Red Meat

Kimberly D. Siegmund, Robert S. Sandler, Peter Lance, 2010, Cancer Epidemiology, Biomarkers & Prevention.

MTHFR Genotype and Colorectal Adenoma Recurrence: Data from a Double-blind Placebo-controlled Clinical Trial

Elizabeth L. Barry, J. Baron, D. Ahnen, 2008, Cancer Epidemiology Biomarkers & Prevention.

Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome.

Aung Ko Win, J. Potter, G. Giles, 2016, International journal of epidemiology.

Identification and characterization of functional risk variants for colorectal cancer mapping to chromosome 11q23.1.

Elizabeth L. Barry, Simon G. Coetzee, G. Coetzee, 2014, Human molecular genetics.

Urinary Metabolites of Prostanoids and Risk of Recurrent Colorectal Adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS)

Patrick T. Bradshaw, Robert S. Sandler, John A. Baron, 2015, Cancer Prevention Research.

Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM): Rationale for Study Design

Grant D. Huang, P. Peduzzi, P. Guarino, 2017, The American Journal of Gastroenterology.

Risks of Colorectal Cancer and Cancer-Related Mortality in Familial Colorectal Cancer Type X and Lynch Syndrome Families.

Aung Ko Win, L. Le Marchand, P. Newcomb, 2018, Journal of the National Cancer Institute.

Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.

Aung Ko Win, J. Potter, G. Giles, 2015, Journal of the National Cancer Institute.

Underutilization of Lynch Syndrome Screening at Two Large Veterans Affairs Medical Centers

Swati G. Patel, D. Ahnen, E. Stoffel, 2020, Digestive Diseases and Sciences.

The kinetic organization of the ulcer-associated cell lineage (UACL): delineation of a novel putative stem-cell region.

D. Ahnen, R. Playford, N. Wright, 1994, Epithelial cell biology.

Red meat and poultry intake, polymorphisms in the nucleotide excision repair and mismatch repair pathways and colorectal cancer risk.

M. Stern, R. Corral, A. Joshi, 2009, Carcinogenesis.

A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy.

David S Alberts, Stephanie A Smith-Warner, Timothy R Church, 2009, Gastroenterology.

Can the Sum of Adenoma Diameters (Adenoma Bulk) on Index Examination Predict Risk of Metachronous Advanced Neoplasia?

R. Bostick, J. Baron, D. Ahnen, 2017, Journal of clinical gastroenterology.

Colorectal Cancer: Genetics is Changing Everything.

D. Ahnen, Joshua C. Obuch, 2016, Gastroenterology clinics of North America.

Prevention of interval colorectal cancers: what every clinician needs to know.

Swati G. Patel, D. Ahnen, 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Sessile serrated adenomas: an evidence-based guide to management.

Seth D. Crockett, J. Baron, D. Ahnen, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

The Association of Age and Race and the Risk of Large Bowel Polyps

Elizabeth L. Barry, J. Baron, D. Ahnen, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Potential impact of family history–based screening guidelines on the detection of early‐onset colorectal cancer

Aung Ko Win, S. Thibodeau, L. Le Marchand, 2020, Cancer.

Colonoscopy Withdrawal Time and Risk of Neoplasia at 5 Years: Results From VA Cooperative Studies Program 380

D. Lieberman, D. Ahnen, D. Weiss, 2010, The American Journal of Gastroenterology.

Using the Results of a Baseline and a Surveillance Colonoscopy to Predict Recurrent Adenomas With High-Risk Characteristics

H. Welch, J. Baron, R. Sandler, 2009, Annals of Internal Medicine.

High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay.

Xuan Jiang, Peter Lance, David I. Smith, 2009, Gastroenterology.

CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment

C. Ulrich, J. Baron, R. Sandler, 2012, Cancer Causes & Control.

Prevalence of Advanced Colorectal Neoplasia in Veterans

Timothy D. Imler, Cynthia S. Johnson, Charles J. Kahi, 2021, Journal of clinical gastroenterology.

Can Colonoscopy Remain Cost-Effective for Colorectal Cancer Screening? The Impact of Practice Patterns and the Will Rogers Phenomenon on Costs

D. Ahnen, G. Austin, Gregory L Austin, 2013, The American Journal of Gastroenterology.

One-Year Risk for Advanced Colorectal Neoplasia: U.S. Versus U.K. Risk-Stratification Guidelines

E. Jacobs, J. Baron, D. Lieberman, 2012, Annals of Internal Medicine.

NCCN Guidelines Insights: Colorectal Cancer Screening, Version 1.2018.

M. Dwyer, G. Cooper, S. Regenbogen, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

Carcinogen metabolism genes, red meat and poultry intake, and colorectal cancer risk

L. Marchand, M. Stern, R. Corral, 2012, International journal of cancer.

Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives

Aung Ko Win, J. Potter, G. Giles, 2014, Gut.

The Association of Tumor Microsatellite Instability Phenotype with Family History of Colorectal Cancer

J. Potter, D. Seminara, J. Hopper, 2009, Cancer Epidemiology Biomarkers & Prevention.

Practical Opportunities to Improve Early Detection and Prevention of Colorectal Cancer (CRC) in Members of High-Risk Families

Swati G. Patel, D. Ahnen, J. Lowery, 2015, Digestive Diseases and Sciences.

CLINICAL-ALIMENTARY TRACT Five-Year Colon Surveillance After Screening Colonoscopy

R. Sampliner, D. Lieberman, G. Chejfec, 2007 .

Association between body mass index and colorectal neoplasia at follow-up colonoscopy: a pooling study.

E. Jacobs, J. Baron, A. Schatzkin, 2009, American journal of epidemiology.

Body mass index, calcium supplementation and risk of colorectal adenomas

Elizabeth L. Barry, G. Beck, R. Bostick, 2018, International journal of cancer.

Activating mutation in MET oncogene in familial colorectal cancer

L. Strong, H. Anton-Culver, D. Ahnen, 2011, BMC Cancer.

Current Screening and Surveillance Guidelines

Swati G. Patel, D. Ahnen, 2015 .

Acid and gastrin levels following pyloric-preserving pancreaticoduodenectomy.

L. Fink, D. Ahnen, N. Pearlman, 1986, Archives of Surgery.

A randomized trial of folic acid to prevent colorectal adenomas

T. Byers, J. Baron, T. Church, 2005 .

Screening for Colon Polyps and Cancer

Swati G. Patel, D. Ahnen, 2013 .

Design and Baseline Characteristics of Participants in a Phase III Randomized Trial of Celecoxib and Selenium for Colorectal Adenoma Prevention

Chiu-Hsieh Hsu, D. Alberts, A. Bhattacharyya, 2012, Cancer Prevention Research.

Measures for ascertaining use of colorectal cancer screening in behavioral, health services, and epidemiologic research.

B. Rimer, D. Ahnen, C. Klabunde, 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

First-degree relatives of patients with advanced colorectal adenomas have an increased prevalence of colorectal cancer.

T. Byers, D. Lieberman, D. Ahnen, 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Community-based Preferences for Stool Cards versus Colonoscopy in Colorectal Cancer Screening

D. Ahnen, Thomas D. Denberg, Kiel T. Butterfield, 2008, Journal of General Internal Medicine.

A Randomized Trial to Increase Colonoscopy Screening in Members of High-Risk Families in the Colorectal Cancer Family Registry and Cancer Genetics Network

P. Newcomb, R. Sandler, D. Finkelstein, 2014, Cancer Epidemiology, Biomarkers & Prevention.

The Family Health Promotion Project (FHPP): design and baseline data from a randomized trial to increase colonoscopy screening in high risk families.

D. Bowen, R. Sandler, D. Finkelstein, 2012, Contemporary clinical trials.

Proliferating cell nuclear antigen expression in normal, preneoplastic, and neoplastic colonic epithelium of the rat.

D. Ahnen, K. Yamada, M. Sato, 1992, Gastroenterology.

Isn’t It Time to Stop Talking About Colonoscopy Quality and Start Doing Something About It?

Swati G. Patel, D. Ahnen, 2011, Digestive Diseases and Sciences.

Increased Risk of Colorectal Cancer Among Family Members of All Ages, Regardless of Age of Index Case at Diagnosis.

Ken R. Smith, C. Ulrich, D. Ahnen, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Increased Risk of Colorectal Cancer Tied to Advanced Colorectal Polyps: An Untapped Opportunity to Screen First-Degree Relatives and Decrease Cancer Burden.

Swati G. Patel, D. Lieberman, D. Ahnen, 2020, American Journal of Gastroenterology.

Is Computed Tomographic Colonography Being Held to a Higher Standard?

D. Ahnen, S. Garg, 2010, Annals of Internal Medicine.

795 Interval Cancer After Total Colonoscopy: Results from a Pooled Analysis of Eight Studies

J. Baron, D. Lieberman, D. Ahnen, 2008 .

Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites.

D. Ahnen, P. Rice, E. Ray, 2001, Cancer research.

Mo1660 ASSESSING COMPETENCE IN COLD SNARE POLYPECTOMY: EVALUATION OF A MODIFIED VERSION OF THE DIRECT OBSERVATION OF POLYPECTOMY SKILLS (DOPYS) TOOL

Swati G. Patel, D. Ahnen, C. Kahi, 2018, Gastrointestinal Endoscopy.

Gastroenterology Trainees Can Easily Learn Histologic Characterization of Diminutive Colorectal Polyps with Narrow Band Imaging (NBI) Presidential Poster: 1979

Swati G. Patel, D. Ahnen, A. Rastogi, 2012 .

Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention.

Elizabeth L. Barry, J. Baron, R. Sandler, 2006, Journal of the National Cancer Institute.

Incidence of Colorectal Cancer Matters

D. Ahnen, S. Winawer, R. Mendelsohn, 2020 .

Familial colorectal cancer risk by subsite of primary cancer: a population‐based study in Utah

K. Smith, D. Ahnen, N. Samadder, 2015, Alimentary pharmacology & therapeutics.

Ability of known susceptibility SNPs to predict colorectal cancer risk for persons with and without a family history

Aung Ko Win, J. Emery, J. Potter, 2018, bioRxiv.

Colorectal Cancer Screening, Version 1.2015.

Dawn Provenzale, James M Ford, Kory Jasperson, 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

Proliferation happens.

T. Byers, D. Ahnen, 1998, JAMA.

Long-term outcome of medical and surgical therapies for GERD: Effects on GERD symptoms and signs

Edward L. Lee, R. Sampliner, D. Ahnen, 2000 .

Advances in Brief Exisulind Induction of Apoptosis Involves Guanosine 3 * , 5 *-Cyclic Monophosphate Phosphodiesterase Inhibition , Protein Kinase G Activation , and Attenuated b-Catenin

G. Piazza, D. Ahnen, B. Zhu, 2000 .

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019.

M. Dwyer, G. Cooper, S. Regenbogen, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Cost Effectiveness Analysis Evaluating Real-Time Characterization of Diminutive Colorectal Polyp Histology using Narrow Band Imaging (NBI)

Sarah K. McGill, Swati G. Patel, D. Ahnen, 2020 .

Inhibition of Extracellular-signal Regulated Kinases 1/2 Is Required for Apoptosis of Human Colon Cancer Cells In vitro by Sulindac Metabolites

D. Ahnen, P. Rice, K. Beard, 2004, Cancer Research.

Cancer Prevention Research Sulindac Metabolites Induce Proteosomal and Lysosomal Degradation of the Epidermal Growth Factor Receptor

D. Ahnen, P. Rice, Heather A. Pangburn, 2010 .

Tissue markers of colon cancer risk.

D. Ahnen, 1999, Gastrointestinal endoscopy.

Abnormal DNA content as a biomarker of large bowel cancer risk and prognosis

D. Ahnen, 1992, Journal of cellular biochemistry. Supplement.

Cyclooxygenase-2 Polymorphisms, Aspirin Treatment, and Risk of Colorectal Adenoma Recurrence – Data from a Randomized Clinical Trial

R. Sandler, D. Ahnen, E. Barry, 2009 .

Design and Baseline Characteristics of Participants in a Phase III Randomized Trial of Celecoxib and Selenium for Colorectal Adenoma Prevention

Chiu-Hsieh Hsu, D. Alberts, A. Bhattacharyya, 2012, Cancer Prevention Research.

Ability of known susceptibility SNPs to predict colorectal cancer risk for persons with and without a family history

Aung Ko Win, J. Emery, J. Potter, 2018, Familial Cancer.

Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer

Aung Ko Win, J. Potter, G. Giles, 2016, Cancer Epidemiology, Biomarkers and Prevention.

Cyclooxygenase-2 Polymorphisms, Aspirin Treatment, and Risk for Colorectal Adenoma Recurrence—Data from a Randomized Clinical Trial

Elizabeth L. Barry, J. Baron, R. Sandler, 2009, Cancer Epidemiology, Biomarkers and Prevention.

A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas.

Elizabeth L. Barry, G. Beck, R. Bostick, 2015, The New England journal of medicine.

Identification of Lynch syndrome among patients with colorectal cancer.

J. Potter, L. Aaltonen, J. Hopper, 2012, JAMA.

Sulindac independently modulates extracellular signal–regulated kinase 1/2 and cyclic GMP–dependent protein kinase signaling pathways

D. Ahnen, P. Rice, Stevany L. Peters, 2006, Molecular Cancer Therapeutics.

Colorectal cancer statistics, 2017

A. Jemal, R. Siegel, K. Miller, 2017, CA: a cancer journal for clinicians.

A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy.

D. Alberts, A. Zauber, E. Jacobs, 2009, Gastroenterology.

The Association of Lifestyle and Dietary Factors with the Risk for Serrated Polyps of the Colorectum

Elizabeth L. Barry, J. Baron, J. Gui, 2009, Cancer Epidemiology, Biomarkers & Prevention.

Regional variability of colonocyte growth and differentiation in the rat

D. Ahnen, M. Sato, D. Ahnen, 1992, The Anatomical record.

Incidence Matters.

D. Ahnen, S. Winawer, R. Mendelsohn, 2019, Gastroenterology.

Association between body mass index and colorectal neoplasia at follow-up colonoscopy: a pooling study.

E. Jacobs, J. Baron, A. Schatzkin, 2009, American journal of epidemiology.

CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment

Elizabeth L. Barry, C. Ulrich, J. Baron, 2012, Cancer Causes & Control.

Serial observations of colonic carcinogenesis in the rat. Premalignant mucosa binds Ulex europeus agglutinin.

D. Ahnen, W. Brown, Y. Shioda, 1987, Gastroenterology.

Lessons from the genetics of colon cancer.

D. Ahnen, 1990, Scandinavian journal of gastroenterology. Supplement.

Sulindac metabolites inhibit epidermal growth factor receptor activation and expression

D. Ahnen, P. Rice, H. Kraus, 2005, Journal of carcinogenesis.

Sulindac Metabolites Induce Proteosomal and Lysosomal Degradation of the Epidermal Growth Factor Receptor

D. Ahnen, P. Rice, H. Pangburn, 2010, Cancer Prevention Research.

Acceleration in colorectal carcinogenesis: the hare, the tortoise or myth?

D. Ahnen, F. Macrae, 2012, Gut.

Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on Outcome.

Elizabeth L. Barry, R. Bostick, J. Baron, 2017, Gastroenterology.